title: Bioactivation of benzocaine to a methaemoglobin-forming metabolite by rat and human microsomes in vitro.
abstract: Benzocaine-mediated methaemoglobin-generation was compared with that of dapsone in vitro. Direct incubation of benzocaine with washed human erythrocytes alone at up to 15 mM did not result in significant methaemoglobin formation (0.4 ± 0.1%). With rat microsomes, dapsone-dependent methaemoglobin formation was almost two-fold that of benzocaine at 30 min (56.5 ± 0.7% vs 31.6 ± 2.4% P < 0.005)). Benzocaine-mediated methaemoglobin formation was significantly reduced in the presence of DDC (diethyldithiocarbamate) at the 10 (P < 0.005) and 20 (P < 0.025) min time points. At 30 min, cimetidine reduced benzocaine-mediated methaemoglobin from 34.4 ± 8.7% to less than 3% (P < 0.005). The methaemoglobin forming capacity of dapsone was significantly inhibited at all three time points by both DDC (P < 0.005) and cimetidine (P < 0.005). Incubation of benzocaine with microsomes from five human livers showed that each liver produced methaemoglobin-forming metabolites. No inhibitory effect was seen with DDC, although cimetidine caused a significant reduction (32.8 ± 12.4% overall) in benzocaine-mediated methaemoglobin formation in the four livers tested.
authors.affiliation: Mechanisms of Drug Toxicity Group, Department of Pharmaceutical Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, UK.
authors.forename: M D
authors.initials: MD
authors.lastname: Coleman
authors.forename: C H
authors.initials: CH
authors.lastname: Taylor